Peripheral Treg Cell Senescence & Serum Total Cholesterol Level - Trial NCT05680844
Access comprehensive clinical trial information for NCT05680844 through Pure Global AI's free database. This phase not specified trial is sponsored by Tianjin Medical University and is currently Recruiting. The study focuses on Hypercholesterolemia. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Tianjin Medical University
Timeline & Enrollment
N/A
Jan 01, 2023
Mar 31, 2023
Primary Outcome
Treg cell senescence
Summary
Hypercholesterolemia is a risk factor for the occurrence and development of atherosclerosis.
 Recent animal studies have found that increased serum cholesterol level is associated with
 peripheral Treg cell senescence, but clinical evidence is still lacking. The purpose of this
 study is to analyze the correlation between human peripheral Treg cell senescence and serum
 total cholesterol level using clinical blood samples, thus laying a foundation for the
 establishment of novel therapeutic strategies for atherosclerosis based on the regulation of
 Treg cell senescence.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05680844
Non-Device Trial